Irinotecan and mismatch repair deficiency

被引：0
|
作者：
Power, D. G. [1 ]
Feilchenfeldt, J. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Div, New York, NY 10021 USA
[2] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷 / 02期
关键词：
ADVANCED COLORECTAL-CANCER; RANDOMIZED PHASE-III; MICROSATELLITE INSTABILITY; ADJUVANT; TRIAL;
D O I：
10.1093/annonc/mdp550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer
    Bendardaf, R.
    Lamlum, H.
    Ristamaki, R.
    Korkeila, E.
    Syrjanen, K.
    Pyrhonen, S.
    TUMOR BIOLOGY, 2007, 28 (04) : 212 - 220
  • [42] Prevalence of DNA Mismatch Repair Deficiency in Endometrial Cancer Using Immunohistochemistry
    Mehdizadeh, Behnoush
    Gharib, Masoumeh
    Jafarian, Amir Hossein
    Afzalaghaee, Monavvar
    Shandiz, Fateme Homaee
    Irajpour, Amirhosein
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2022, 15 (08)
  • [43] Evaluation of DNA Mismatch Repair Protein Deficiency in Primary Endometrial Carcinoma
    Kumar, Pankaj
    Gupta, Parikshaa
    Gupta, Nalini
    Rajwanshi, Arvind
    Rai, Bhavana
    Shalini, Gainder
    JOURNAL OF GYNECOLOGIC SURGERY, 2019, 35 (03) : 177 - 183
  • [44] Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort
    Lavoine, N.
    Colas, C.
    Muleris, M.
    Bodo, S.
    Duval, A.
    Entz-Werle, N.
    Coulet, F.
    Cabaret, O.
    Andreiuolo, F.
    Charpy, C.
    Sebille, G.
    Wang, Q.
    Lejeune, S.
    Buisine, M. P.
    Leroux, D.
    Couillault, G.
    Leverger, G.
    Fricker, J. P.
    Guimbaud, R.
    Mathieu-Dramard, M.
    Jedraszak, G.
    Cohen-Hagenauer, O.
    Guerrini-Rousseau, L.
    Bourdeaut, F.
    Grill, J.
    Caron, O.
    Baert-Dusermont, S.
    Tinat, J.
    Bougeard, G.
    Frebourg, T.
    Brugieres, L.
    JOURNAL OF MEDICAL GENETICS, 2015, 52 (11) : 770 - 778
  • [45] A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer
    Pal, Tuya
    Permuth-Wey, Jenny
    Sellers, Thomas A.
    CANCER, 2008, 113 (04) : 733 - 742
  • [46] Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications
    Doghri, Raoudha
    Houcine, Yoldez
    Boujelbene, Nadia
    Driss, Maha
    Charfi, Lamia
    Abbes, Imene
    Mrad, Karima
    Sellami, Rini
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (09) : 678 - 682
  • [47] Mismatch repair deficiency in ovarian cancer - Molecular characteristics and clinical implications
    Xiao, Xue
    Melton, David W.
    Gourley, Charlie
    GYNECOLOGIC ONCOLOGY, 2014, 132 (02) : 506 - 512
  • [48] DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome
    Poulogiannis, George
    Frayling, Ian M.
    Arends, Mark J.
    HISTOPATHOLOGY, 2010, 56 (02) : 167 - 179
  • [49] Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond
    Wong, Hui-li
    Christie, Michael
    Gately, Lucy
    Tie, Jeanne
    Lee, Belinda
    Semira, Christine
    Lok, Sheau Wen
    Wong, Rachel
    Gibbs, Peter
    FUTURE ONCOLOGY, 2018, 14 (26) : 2725 - 2740
  • [50] Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome
    Farah, Roula A.
    Maalouf, Farid
    Chahine, Nassim Abi
    Farhat, Hussein
    Campbell, Brittany
    Zhukova, Nataliya
    Durno, Carol
    Aronson, Melyssa
    Hawkins, Cynthia
    Bouffet, Eric
    Tabori, Uri
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2019, 62 (08)
12345